The purpose of this study is to evaluate the efficacy and safety of belimumab, in combination
with azathioprine, for the maintenance of remission following a standard induction regimen in
patients with Wegener's granulomatosis or microscopic polyangiitis. The random assignment in
this study is "1 to 1" which means that participants have an equal chance of receiving
belimumab or placebo.